APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urine and Oral Fluid Drug Tests

Compare research editions
View pricing & licenses

Selected research

Industry Research

Urine and Oral Fluid Drug Tests Industry Research Report 2026

26 December 2025138 pages

Choose your research edition.

Industry ResearchUrine and Oral Fluid Drug Tests Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Urine and Oral Fluid Drug Tests Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Urine and Oral Fluid Drug Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urine and Oral Fluid Drug Tests Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Urine and Oral Fluid Drug Tests Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Urine and Oral Fluid Drug Tests market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Urine and Oral Fluid Drug Tests is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Urine and Oral Fluid Drug Tests is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Urine and Oral Fluid Drug Tests is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Urine and Oral Fluid Drug Tests include 77 Elektronika Kft., Arkray, Beckman Coulter, Inova Diagnostics, Quest Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Aicon Biotechnology Co., Ltd. and Aiwei Technology Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Urine and Oral Fluid Drug Tests market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Urine and Oral Fluid Drug Tests Market by Company

77 Elektronika Kft.

Arkray

Beckman Coulter

Inova Diagnostics

Quest Diagnostics

Siemens Healthineers

Thermo Fisher Scientific

Aicon Biotechnology Co., Ltd.

Aiwei Technology Co., Ltd.

Beijing Kuer Technology Co., Ltd.

Beijing Manor Biopharmaceutical Co., Ltd.

Beijing Wantai Biopharmaceutical Co., Ltd.

Chengdu Union Biotechnology Co., Ltd.

Decheng Biotechnology Co., Ltd.

Guangzhou Wanfu Biological Technology Co., Ltd.

Roche

Wancheng Biotechnology Co., Ltd.

Abbott

Urine and Oral Fluid Drug Tests Segment by Type

Oral Fluid Test

Urine Test

Urine and Oral Fluid Drug Tests Segment by Application

Toxicology Testing

Forensic Evidence Collection

Personal Use

Urine and Oral Fluid Drug Tests Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urine and Oral Fluid Drug Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urine and Oral Fluid Drug Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urine and Oral Fluid Drug Tests.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Urine and Oral Fluid Drug Tests manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Urine and Oral Fluid Drug Tests by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Urine and Oral Fluid Drug Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Urine and Oral Fluid Drug Tests Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Urine and Oral Fluid Drug Tests Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Urine and Oral Fluid Drug Tests Sales Market Share by Manufacturers (2021-2026) Table 8. Global Urine and Oral Fluid Drug Tests Revenue of Manufacturers (2021-2026) Table 9. Global Urine and Oral Fluid Drug Tests Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Urine and Oral Fluid Drug Tests Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Urine and Oral Fluid Drug Tests Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Urine and Oral Fluid Drug Tests, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Urine and Oral Fluid Drug Tests, Product Type & Application Table 14. Global Urine and Oral Fluid Drug Tests Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Urine and Oral Fluid Drug Tests by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. 77 Elektronika Kft. Company Information Table 19. 77 Elektronika Kft. Business Overview Table 20. 77 Elektronika Kft. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. 77 Elektronika Kft. Urine and Oral Fluid Drug Tests Product Portfolio Table 22. 77 Elektronika Kft. Recent Developments Table 23. Arkray Company Information Table 24. Arkray Business Overview Table 25. Arkray Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Arkray Urine and Oral Fluid Drug Tests Product Portfolio Table 27. Arkray Recent Developments Table 28. Beckman Coulter Company Information Table 29. Beckman Coulter Business Overview Table 30. Beckman Coulter Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Beckman Coulter Urine and Oral Fluid Drug Tests Product Portfolio Table 32. Beckman Coulter Recent Developments Table 33. Inova Diagnostics Company Information Table 34. Inova Diagnostics Business Overview Table 35. Inova Diagnostics Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Inova Diagnostics Urine and Oral Fluid Drug Tests Product Portfolio Table 37. Inova Diagnostics Recent Developments Table 38. Quest Diagnostics Company Information Table 39. Quest Diagnostics Business Overview Table 40. Quest Diagnostics Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Quest Diagnostics Urine and Oral Fluid Drug Tests Product Portfolio Table 42. Quest Diagnostics Recent Developments Table 43. Siemens Healthineers Company Information Table 44. Siemens Healthineers Business Overview Table 45. Siemens Healthineers Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Siemens Healthineers Urine and Oral Fluid Drug Tests Product Portfolio Table 47. Siemens Healthineers Recent Developments Table 48. Thermo Fisher Scientific Company Information Table 49. Thermo Fisher Scientific Business Overview Table 50. Thermo Fisher Scientific Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Thermo Fisher Scientific Urine and Oral Fluid Drug Tests Product Portfolio Table 52. Thermo Fisher Scientific Recent Developments Table 53. Aicon Biotechnology Co., Ltd. Company Information Table 54. Aicon Biotechnology Co., Ltd. Business Overview Table 55. Aicon Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Aicon Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 57. Aicon Biotechnology Co., Ltd. Recent Developments Table 58. Aiwei Technology Co., Ltd. Company Information Table 59. Aiwei Technology Co., Ltd. Business Overview Table 60. Aiwei Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Aiwei Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 62. Aiwei Technology Co., Ltd. Recent Developments Table 63. Beijing Kuer Technology Co., Ltd. Company Information Table 64. Beijing Kuer Technology Co., Ltd. Business Overview Table 65. Beijing Kuer Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Beijing Kuer Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 67. Beijing Kuer Technology Co., Ltd. Recent Developments Table 68. Beijing Manor Biopharmaceutical Co., Ltd. Company Information Table 69. Beijing Manor Biopharmaceutical Co., Ltd. Business Overview Table 70. Beijing Manor Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Beijing Manor Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 72. Beijing Manor Biopharmaceutical Co., Ltd. Recent Developments Table 73. Beijing Wantai Biopharmaceutical Co., Ltd. Company Information Table 74. Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview Table 75. Beijing Wantai Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Beijing Wantai Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 77. Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments Table 78. Chengdu Union Biotechnology Co., Ltd. Company Information Table 79. Chengdu Union Biotechnology Co., Ltd. Business Overview Table 80. Chengdu Union Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Chengdu Union Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 82. Chengdu Union Biotechnology Co., Ltd. Recent Developments Table 83. Decheng Biotechnology Co., Ltd. Company Information Table 84. Decheng Biotechnology Co., Ltd. Business Overview Table 85. Decheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Decheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 87. Decheng Biotechnology Co., Ltd. Recent Developments Table 88. Guangzhou Wanfu Biological Technology Co., Ltd. Company Information Table 89. Guangzhou Wanfu Biological Technology Co., Ltd. Business Overview Table 90. Guangzhou Wanfu Biological Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Guangzhou Wanfu Biological Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 92. Guangzhou Wanfu Biological Technology Co., Ltd. Recent Developments Table 93. Roche Company Information Table 94. Roche Business Overview Table 95. Roche Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Roche Urine and Oral Fluid Drug Tests Product Portfolio Table 97. Roche Recent Developments Table 98. Wancheng Biotechnology Co., Ltd. Company Information Table 99. Wancheng Biotechnology Co., Ltd. Business Overview Table 100. Wancheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Wancheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio Table 102. Wancheng Biotechnology Co., Ltd. Recent Developments Table 103. Abbott Company Information Table 104. Abbott Business Overview Table 105. Abbott Urine and Oral Fluid Drug Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Abbott Urine and Oral Fluid Drug Tests Product Portfolio Table 107. Abbott Recent Developments Table 108. Global Urine and Oral Fluid Drug Tests Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Urine and Oral Fluid Drug Tests Sales by Region (2021-2026) & (K Units) Table 110. Global Urine and Oral Fluid Drug Tests Sales Market Share by Region (2021-2026) Table 111. Global Urine and Oral Fluid Drug Tests Sales by Region (2027-2032) & (K Units) Table 112. Global Urine and Oral Fluid Drug Tests Sales Market Share by Region (2027-2032) Table 113. Global Urine and Oral Fluid Drug Tests Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Urine and Oral Fluid Drug Tests Revenue Market Share by Region (2021-2026) Table 115. Global Urine and Oral Fluid Drug Tests Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Urine and Oral Fluid Drug Tests Revenue Market Share by Region (2027-2032) Table 117. North America Urine and Oral Fluid Drug Tests Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Urine and Oral Fluid Drug Tests Sales by Country (2021-2026) & (K Units) Table 119. North America Urine and Oral Fluid Drug Tests Sales by Country (2027-2032) & (K Units) Table 120. North America Urine and Oral Fluid Drug Tests Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Urine and Oral Fluid Drug Tests Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Urine and Oral Fluid Drug Tests Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Urine and Oral Fluid Drug Tests Sales by Country (2021-2026) & (K Units) Table 124. Europe Urine and Oral Fluid Drug Tests Sales by Country (2027-2032) & (K Units) Table 125. Europe Urine and Oral Fluid Drug Tests Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Urine and Oral Fluid Drug Tests Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Urine and Oral Fluid Drug Tests Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Urine and Oral Fluid Drug Tests Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Urine and Oral Fluid Drug Tests Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Urine and Oral Fluid Drug Tests Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Urine and Oral Fluid Drug Tests Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Urine and Oral Fluid Drug Tests Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Urine and Oral Fluid Drug Tests Sales by Country (2021-2026) & (K Units) Table 134. South America Urine and Oral Fluid Drug Tests Sales by Country (2027-2032) & (K Units) Table 135. South America Urine and Oral Fluid Drug Tests Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Urine and Oral Fluid Drug Tests Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Urine and Oral Fluid Drug Tests Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Urine and Oral Fluid Drug Tests Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Urine and Oral Fluid Drug Tests Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Urine and Oral Fluid Drug Tests Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Urine and Oral Fluid Drug Tests Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Urine and Oral Fluid Drug Tests Sales by Type (2021-2026) & (K Units) Table 143. Global Urine and Oral Fluid Drug Tests Sales by Type (2027-2032) & (K Units) Table 144. Global Urine and Oral Fluid Drug Tests Sales Market Share by Type (2021-2026) Table 145. Global Urine and Oral Fluid Drug Tests Sales Market Share by Type (2027-2032) Table 146. Global Urine and Oral Fluid Drug Tests Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Urine and Oral Fluid Drug Tests Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Urine and Oral Fluid Drug Tests Revenue Market Share by Type (2021-2026) Table 149. Global Urine and Oral Fluid Drug Tests Revenue Market Share by Type (2027-2032) Table 150. Global Urine and Oral Fluid Drug Tests Price by Type (2021-2026) & (US$/Unit) Table 151. Global Urine and Oral Fluid Drug Tests Price by Type (2027-2032) & (US$/Unit) Table 152. Global Urine and Oral Fluid Drug Tests Sales by Application (2021-2026) & (K Units) Table 153. Global Urine and Oral Fluid Drug Tests Sales by Application (2027-2032) & (K Units) Table 154. Global Urine and Oral Fluid Drug Tests Sales Market Share by Application (2021-2026) Table 155. Global Urine and Oral Fluid Drug Tests Sales Market Share by Application (2027-2032) Table 156. Global Urine and Oral Fluid Drug Tests Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Urine and Oral Fluid Drug Tests Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Urine and Oral Fluid Drug Tests Revenue Market Share by Application (2021-2026) Table 159. Global Urine and Oral Fluid Drug Tests Revenue Market Share by Application (2027-2032) Table 160. Global Urine and Oral Fluid Drug Tests Price by Application (2021-2026) & (US$/Unit) Table 161. Global Urine and Oral Fluid Drug Tests Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Urine and Oral Fluid Drug Tests Distributors List Table 165. Urine and Oral Fluid Drug Tests Customers List Table 166. Urine and Oral Fluid Drug Tests Industry Trends Table 167. Urine and Oral Fluid Drug Tests Industry Drivers Table 168. Urine and Oral Fluid Drug Tests Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Urine and Oral Fluid Drug Tests Product Image Figure 5. Global Urine and Oral Fluid Drug Tests Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Urine and Oral Fluid Drug Tests Market Size (2021-2032) & (US$ Million) Figure 7. Global Urine and Oral Fluid Drug Tests Sales (2021-2032) & (K Units) Figure 8. Global Urine and Oral Fluid Drug Tests Average Price (US$/Unit) & (2021-2032) Figure 9. Oral Fluid Test Product Image Figure 10. Urine Test Product Image Figure 11. Toxicology Testing Product Image Figure 12. Forensic Evidence Collection Product Image Figure 13. Personal Use Product Image Figure 14. Global Urine and Oral Fluid Drug Tests Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Urine and Oral Fluid Drug Tests, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Urine and Oral Fluid Drug Tests Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Urine and Oral Fluid Drug Tests Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Urine and Oral Fluid Drug Tests Sales by Region in 2025 Figure 20. Global Urine and Oral Fluid Drug Tests Revenue by Region in 2025 Figure 21. North America Urine and Oral Fluid Drug Tests Market Size by Country in 2025 Figure 22. North America Urine and Oral Fluid Drug Tests Sales Market Share by Country (2021-2032) Figure 23. North America Urine and Oral Fluid Drug Tests Revenue Market Share by Country (2021-2032) Figure 24. United States Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Urine and Oral Fluid Drug Tests Market Size by Country in 2025 Figure 28. Europe Urine and Oral Fluid Drug Tests Sales Market Share by Country (2021-2032) Figure 29. Europe Urine and Oral Fluid Drug Tests Revenue Market Share by Country (2021-2032) Figure 30. Germany Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Urine and Oral Fluid Drug Tests Market Size by Country in 2025 Figure 41. Asia Pacific Urine and Oral Fluid Drug Tests Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Urine and Oral Fluid Drug Tests Revenue Market Share by Country (2021-2032) Figure 43. China Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Urine and Oral Fluid Drug Tests Market Size by Country in 2025 Figure 52. South America Urine and Oral Fluid Drug Tests Sales Market Share by Country (2021-2032) Figure 53. South America Urine and Oral Fluid Drug Tests Revenue Market Share by Country (2021-2032) Figure 54. Brazil Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Urine and Oral Fluid Drug Tests Market Size by Country in 2025 Figure 58. Middle East and Africa Urine and Oral Fluid Drug Tests Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Urine and Oral Fluid Drug Tests Revenue Market Share by Country (2021-2032) Figure 60. Egypt Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Urine and Oral Fluid Drug Tests Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Urine and Oral Fluid Drug Tests Sales Market Share by Type (2021-2032) Figure 66. Global Urine and Oral Fluid Drug Tests Revenue Market Share by Type (2021-2032) Figure 67. Global Urine and Oral Fluid Drug Tests Price (US$/Unit) by Type (2021-2032) Figure 68. Global Urine and Oral Fluid Drug Tests Sales Market Share by Application (2021-2032) Figure 69. Global Urine and Oral Fluid Drug Tests Revenue Market Share by Application (2021-2032) Figure 70. Global Urine and Oral Fluid Drug Tests Price (US$/Unit) by Application (2021-2032) Figure 71. Urine and Oral Fluid Drug Tests Value Chain Figure 72. Urine and Oral Fluid Drug Tests Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Urine and Oral Fluid Drug Tests Industry Opportunities and Challenges

Scope & coverage.

Types
  • Oral Fluid Test
  • Urine Test
Applications
  • Toxicology Testing
  • Forensic Evidence Collection
  • Personal Use
Companies covered
  • 77 Elektronika Kft.
  • Arkray
  • Beckman Coulter
  • Inova Diagnostics
  • Quest Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Aicon Biotechnology Co., Ltd.
  • Aiwei Technology Co., Ltd.
  • Beijing Kuer Technology Co., Ltd.
  • Beijing Manor Biopharmaceutical Co., Ltd.
  • Beijing Wantai Biopharmaceutical Co., Ltd.
  • Chengdu Union Biotechnology Co., Ltd.
  • Decheng Biotechnology Co., Ltd.
  • Guangzhou Wanfu Biological Technology Co., Ltd.
  • Roche
  • Wancheng Biotechnology Co., Ltd.
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Urine and Oral Fluid Drug Tests Market Size (2021-2032)
  4. 2.2.2 Global Urine and Oral Fluid Drug Tests Sales (2021-2032)
  5. 2.2.3 Global Urine and Oral Fluid Drug Tests Market Average Price (2021-2032)
  6. 2.3 Urine and Oral Fluid Drug Tests by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Oral Fluid Test
  9. 2.3.3 Urine Test
  10. 2.4 Urine and Oral Fluid Drug Tests by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Toxicology Testing
  13. 2.4.3 Forensic Evidence Collection
  14. 2.4.4 Personal Use
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Urine and Oral Fluid Drug Tests Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Urine and Oral Fluid Drug Tests Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Urine and Oral Fluid Drug Tests Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Urine and Oral Fluid Drug Tests Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Urine and Oral Fluid Drug Tests Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Urine and Oral Fluid Drug Tests, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Urine and Oral Fluid Drug Tests, Product Type & Application
  8. 3.8 Global Manufacturers of Urine and Oral Fluid Drug Tests, Established Date
  9. 3.9 Global Urine and Oral Fluid Drug Tests Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 77 Elektronika Kft.
  2. 4.1.1 77 Elektronika Kft. Company Information
  3. 4.1.2 77 Elektronika Kft. Business Overview
  4. 4.1.3 77 Elektronika Kft. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 77 Elektronika Kft. Urine and Oral Fluid Drug Tests Product Portfolio
  6. 4.1.5 77 Elektronika Kft. Recent Developments
  7. 4.2 Arkray
  8. 4.2.1 Arkray Company Information
  9. 4.2.2 Arkray Business Overview
  10. 4.2.3 Arkray Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Arkray Urine and Oral Fluid Drug Tests Product Portfolio
  12. 4.2.5 Arkray Recent Developments
  13. 4.3 Beckman Coulter
  14. 4.3.1 Beckman Coulter Company Information
  15. 4.3.2 Beckman Coulter Business Overview
  16. 4.3.3 Beckman Coulter Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Beckman Coulter Urine and Oral Fluid Drug Tests Product Portfolio
  18. 4.3.5 Beckman Coulter Recent Developments
  19. 4.4 Inova Diagnostics
  20. 4.4.1 Inova Diagnostics Company Information
  21. 4.4.2 Inova Diagnostics Business Overview
  22. 4.4.3 Inova Diagnostics Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Inova Diagnostics Urine and Oral Fluid Drug Tests Product Portfolio
  24. 4.4.5 Inova Diagnostics Recent Developments
  25. 4.5 Quest Diagnostics
  26. 4.5.1 Quest Diagnostics Company Information
  27. 4.5.2 Quest Diagnostics Business Overview
  28. 4.5.3 Quest Diagnostics Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Quest Diagnostics Urine and Oral Fluid Drug Tests Product Portfolio
  30. 4.5.5 Quest Diagnostics Recent Developments
  31. 4.6 Siemens Healthineers
  32. 4.6.1 Siemens Healthineers Company Information
  33. 4.6.2 Siemens Healthineers Business Overview
  34. 4.6.3 Siemens Healthineers Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Siemens Healthineers Urine and Oral Fluid Drug Tests Product Portfolio
  36. 4.6.5 Siemens Healthineers Recent Developments
  37. 4.7 Thermo Fisher Scientific
  38. 4.7.1 Thermo Fisher Scientific Company Information
  39. 4.7.2 Thermo Fisher Scientific Business Overview
  40. 4.7.3 Thermo Fisher Scientific Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Thermo Fisher Scientific Urine and Oral Fluid Drug Tests Product Portfolio
  42. 4.7.5 Thermo Fisher Scientific Recent Developments
  43. 4.8 Aicon Biotechnology Co., Ltd.
  44. 4.8.1 Aicon Biotechnology Co., Ltd. Company Information
  45. 4.8.2 Aicon Biotechnology Co., Ltd. Business Overview
  46. 4.8.3 Aicon Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Aicon Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  48. 4.8.5 Aicon Biotechnology Co., Ltd. Recent Developments
  49. 4.9 Aiwei Technology Co., Ltd.
  50. 4.9.1 Aiwei Technology Co., Ltd. Company Information
  51. 4.9.2 Aiwei Technology Co., Ltd. Business Overview
  52. 4.9.3 Aiwei Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Aiwei Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  54. 4.9.5 Aiwei Technology Co., Ltd. Recent Developments
  55. 4.10 Beijing Kuer Technology Co., Ltd.
  56. 4.10.1 Beijing Kuer Technology Co., Ltd. Company Information
  57. 4.10.2 Beijing Kuer Technology Co., Ltd. Business Overview
  58. 4.10.3 Beijing Kuer Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Beijing Kuer Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  60. 4.10.5 Beijing Kuer Technology Co., Ltd. Recent Developments
  61. 4.11 Beijing Manor Biopharmaceutical Co., Ltd.
  62. 4.11.1 Beijing Manor Biopharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Beijing Manor Biopharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Beijing Manor Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Beijing Manor Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  66. 4.11.5 Beijing Manor Biopharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Beijing Wantai Biopharmaceutical Co., Ltd.
  68. 4.12.1 Beijing Wantai Biopharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Beijing Wantai Biopharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Beijing Wantai Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Beijing Wantai Biopharmaceutical Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  72. 4.12.5 Beijing Wantai Biopharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Chengdu Union Biotechnology Co., Ltd.
  74. 4.13.1 Chengdu Union Biotechnology Co., Ltd. Company Information
  75. 4.13.2 Chengdu Union Biotechnology Co., Ltd. Business Overview
  76. 4.13.3 Chengdu Union Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Chengdu Union Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  78. 4.13.5 Chengdu Union Biotechnology Co., Ltd. Recent Developments
  79. 4.14 Decheng Biotechnology Co., Ltd.
  80. 4.14.1 Decheng Biotechnology Co., Ltd. Company Information
  81. 4.14.2 Decheng Biotechnology Co., Ltd. Business Overview
  82. 4.14.3 Decheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Decheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  84. 4.14.5 Decheng Biotechnology Co., Ltd. Recent Developments
  85. 4.15 Guangzhou Wanfu Biological Technology Co., Ltd.
  86. 4.15.1 Guangzhou Wanfu Biological Technology Co., Ltd. Company Information
  87. 4.15.2 Guangzhou Wanfu Biological Technology Co., Ltd. Business Overview
  88. 4.15.3 Guangzhou Wanfu Biological Technology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Guangzhou Wanfu Biological Technology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  90. 4.15.5 Guangzhou Wanfu Biological Technology Co., Ltd. Recent Developments
  91. 4.16 Roche
  92. 4.16.1 Roche Company Information
  93. 4.16.2 Roche Business Overview
  94. 4.16.3 Roche Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Roche Urine and Oral Fluid Drug Tests Product Portfolio
  96. 4.16.5 Roche Recent Developments
  97. 4.17 Wancheng Biotechnology Co., Ltd.
  98. 4.17.1 Wancheng Biotechnology Co., Ltd. Company Information
  99. 4.17.2 Wancheng Biotechnology Co., Ltd. Business Overview
  100. 4.17.3 Wancheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Wancheng Biotechnology Co., Ltd. Urine and Oral Fluid Drug Tests Product Portfolio
  102. 4.17.5 Wancheng Biotechnology Co., Ltd. Recent Developments
  103. 4.18 Abbott
  104. 4.18.1 Abbott Company Information
  105. 4.18.2 Abbott Business Overview
  106. 4.18.3 Abbott Urine and Oral Fluid Drug Tests Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Abbott Urine and Oral Fluid Drug Tests Product Portfolio
  108. 4.18.5 Abbott Recent Developments
5 Global Urine and Oral Fluid Drug Tests Market Scenario by Region
  1. 5.1 Global Urine and Oral Fluid Drug Tests Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Urine and Oral Fluid Drug Tests Sales by Region: 2021-2032
  3. 5.2.1 Global Urine and Oral Fluid Drug Tests Sales by Region: 2021-2026
  4. 5.2.2 Global Urine and Oral Fluid Drug Tests Sales by Region: 2027-2032
  5. 5.3 Global Urine and Oral Fluid Drug Tests Revenue by Region: 2021-2032
  6. 5.3.1 Global Urine and Oral Fluid Drug Tests Revenue by Region: 2021-2026
  7. 5.3.2 Global Urine and Oral Fluid Drug Tests Revenue by Region: 2027-2032
  8. 5.4 North America Urine and Oral Fluid Drug Tests Market Facts & Figures by Country
  9. 5.4.1 North America Urine and Oral Fluid Drug Tests Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Urine and Oral Fluid Drug Tests Sales by Country (2021-2032)
  11. 5.4.3 North America Urine and Oral Fluid Drug Tests Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Urine and Oral Fluid Drug Tests Market Facts & Figures by Country
  16. 5.5.1 Europe Urine and Oral Fluid Drug Tests Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Urine and Oral Fluid Drug Tests Sales by Country (2021-2032)
  18. 5.5.3 Europe Urine and Oral Fluid Drug Tests Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Urine and Oral Fluid Drug Tests Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Urine and Oral Fluid Drug Tests Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Urine and Oral Fluid Drug Tests Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Urine and Oral Fluid Drug Tests Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Urine and Oral Fluid Drug Tests Market Facts & Figures by Country
  41. 5.7.1 South America Urine and Oral Fluid Drug Tests Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Urine and Oral Fluid Drug Tests Sales by Country (2021-2032)
  43. 5.7.3 South America Urine and Oral Fluid Drug Tests Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Urine and Oral Fluid Drug Tests Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Urine and Oral Fluid Drug Tests Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Urine and Oral Fluid Drug Tests Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Urine and Oral Fluid Drug Tests Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Urine and Oral Fluid Drug Tests Sales by Type (2021-2032)
  2. 6.1.1 Global Urine and Oral Fluid Drug Tests Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Urine and Oral Fluid Drug Tests Sales Market Share by Type (2021-2032)
  4. 6.2 Global Urine and Oral Fluid Drug Tests Revenue by Type (2021-2032)
  5. 6.2.1 Global Urine and Oral Fluid Drug Tests Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Urine and Oral Fluid Drug Tests Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Urine and Oral Fluid Drug Tests Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Urine and Oral Fluid Drug Tests Sales by Application (2021-2032)
  2. 7.1.1 Global Urine and Oral Fluid Drug Tests Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Urine and Oral Fluid Drug Tests Sales Market Share by Application (2021-2032)
  4. 7.2 Global Urine and Oral Fluid Drug Tests Revenue by Application (2021-2032)
  5. 7.2.1 Global Urine and Oral Fluid Drug Tests Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Urine and Oral Fluid Drug Tests Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Urine and Oral Fluid Drug Tests Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Urine and Oral Fluid Drug Tests Value Chain Analysis
  2. 8.1.1 Urine and Oral Fluid Drug Tests Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Urine and Oral Fluid Drug Tests Production Mode & Process
  5. 8.2 Urine and Oral Fluid Drug Tests Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Urine and Oral Fluid Drug Tests Distributors
  8. 8.2.3 Urine and Oral Fluid Drug Tests Customers
9 Global Urine and Oral Fluid Drug Tests Analyzing Market Dynamics
  1. 9.1 Urine and Oral Fluid Drug Tests Industry Trends
  2. 9.2 Urine and Oral Fluid Drug Tests Industry Drivers
  3. 9.3 Urine and Oral Fluid Drug Tests Industry Opportunities and Challenges
  4. 9.4 Urine and Oral Fluid Drug Tests Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst